COUNTERPOINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? No
- PMID: 32505305
- DOI: 10.1016/j.chest.2019.12.031
COUNTERPOINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? No
Comment in
-
Rebuttal From Dr Nathan.Chest. 2020 Jun;157(6):1415. doi: 10.1016/j.chest.2019.12.032. Chest. 2020. PMID: 32505306 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical